These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2300267)

  • 21. Studies with bromocriptine. Part 1. "On-off" phenomena.
    Kartznel R; Calne DB
    Neurology; 1976 Jun; 26(6 PT 1):508-10. PubMed ID: 945489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of Parkinson's disease with bromocriptine].
    Castaigne P; Laplane D; Bousser MG; Bories F
    Nouv Presse Med; 1976 Apr; 6(17):1482. PubMed ID: 1037400
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR) for the treatment of acromegaly.
    Plöckinger U; Quabbe HJ
    J Endocrinol Invest; 1991 Dec; 14(11):943-8. PubMed ID: 1806612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bromocriptine and lactation].
    Olesen C; Lous J; Freund KS; Sørensen HT; Olsen J
    Ugeskr Laeger; 1998 Oct; 160(44):6360. PubMed ID: 9810245
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bromocriptine induced cystic tumour regression in advanced prolactinomas (author's transl)].
    Galvan G; Frick J; Irnberger T
    Dtsch Med Wochenschr; 1981 May; 106(20):637-42. PubMed ID: 7227210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Side effects of bromocriptine.
    Kissner DG; Jarrett JC
    N Engl J Med; 1980 Mar; 302(13):749-50. PubMed ID: 7354785
    [No Abstract]   [Full Text] [Related]  

  • 27. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
    Grimes JD; Delgado MR
    Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of oral administration of single rising doses of bromocriptine to produce acute anti-Parkinsonian effects.
    Poewe W; Schelosky L; Kleedorfer B
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):186-7. PubMed ID: 2019851
    [No Abstract]   [Full Text] [Related]  

  • 29. Bromocriptine and gastrin secretion.
    Reding P; de Graef J; Barbier P
    Lancet; 1978 Jun; 1(8075):1202-3. PubMed ID: 77965
    [No Abstract]   [Full Text] [Related]  

  • 30. [The treatment of Parkinson disease using the combination bromocriptine and levodopa].
    Dufresne JJ
    Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793
    [No Abstract]   [Full Text] [Related]  

  • 31. [A case of toxic psychosis caused by bromocriptine].
    Jimeno Valdés A; Ruiz Otazo AM; Jimeno Bulnes N
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1989; 17(6):386-90. PubMed ID: 2698595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromocriptine and uterine neoplasia.
    Griffith RW
    Br Med J; 1977 Dec; 2(6102):1605. PubMed ID: 589369
    [No Abstract]   [Full Text] [Related]  

  • 33. Mental disorders from low-dose bromocriptine.
    Pearson KC
    N Engl J Med; 1981 Jul; 305(3):173. PubMed ID: 7242593
    [No Abstract]   [Full Text] [Related]  

  • 34. Bromocriptine and levodopa in early combination in Parkinson's disease: first results of the Collaborative European Multicentric Trial.
    Olsson JE
    Adv Neurol; 1990; 53():421-3. PubMed ID: 2239483
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term treatment of Parkinson's disease with bromocriptine.
    Rascol A; Guiraud B; Montastruc JL; David J; Clanet M
    J Neurol Neurosurg Psychiatry; 1979 Feb; 42(2):143-50. PubMed ID: 422961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Puerperal inhibition of lactation with metergoline or bromocriptine].
    Fischer T; Streitmatter A; Gerede A; Frauendorf A; Krause M; Feige A
    Z Geburtshilfe Neonatol; 1995; 199(3):111-5. PubMed ID: 7553254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and long-term tolerability of the slow release oral form of bromocriptine on tumoral and non-tumoral hyperprolactinemia.
    Merola B; Colao A; Caruso E; Sarnacchiaro F; Lancranjan I; Lombardi G; Schettini G
    J Endocrinol Invest; 1992 Mar; 15(3):173-6. PubMed ID: 1624676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothermic action of bromocriptine.
    Calne DB; Claveria LE; Reid JL
    Br J Pharmacol; 1975 May; 54(1):123-4. PubMed ID: 1139073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bromocriptine (Parlodel) in the treatment of Parkinson's disease. Summary of 7 years' experience].
    Delwaide PJ; Schoenen J
    Rev Med Liege; 1983 May; 38(9):362-6. PubMed ID: 6867529
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemia.
    Ciccarelli E; Ghigo E; Mazza E; Andreis M; Massara F; Lancranjan I; Camanni F
    J Endocrinol Invest; 1987 Apr; 10(2):179-82. PubMed ID: 3584856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.